AI in High-Frequency Micro-Ultrasound: Advancing Prostate Imaging from Segmentation to Cancer Detection
Authors:
- Ludovica CellaLCLudovica Cella
- Marco PaciottiMarco Paciotti
- Pier Paolo AvolioPAPier Paolo Avolio
- Vittorio FasuloVFVittorio Fasulo
- Andrea PiccoliniAPAndrea Piccolini
- Rebecca CannetoRCRebecca Canneto
- Giacomo CavadiniGCGiacomo Cavadini
- Luca Di StefanoLSLuca Di Stefano
- Alberto SaitaASAlberto Saita
- Paolo CasalePCPaolo Casale
- Massimo LazzeriMassimo Lazzeri
- Nicolò Maria BuffiNicolò Maria Buffi
Open Access
Abstract
Background/Objective: High-frequency micro-ultrasound (micro-US) offers real-time, high-resolution imaging for prostate cancer. Although artificial intelligence (AI) has shown potential in enhancing micro-US interpretation, a comprehensive review of this emerging field is currently missing. This review synthesizes current evidence on AI applied to ExactVu 29 MHz micro-US for prostate cancer. Methods: PubMed/MEDLINE, Embase, Scopus, Web of Science and the Cochrane Library were searched up to December 2025. Studies were included if they applied machine learning or deep learning directly to 29 MHz micro-US data and reported quantitative performance metrics. Results: Ten studies met the inclusion criteria: six on prostate cancer detection, three on prostate segmentation and one on micro-US–histopathology registration. Detection models ranged from classical quantitative ultrasound machine learning to deep architectures using self-supervision, transformers, multiple-instance learning, ensemble calibration and 3D segmentation-based pipelines. Among core-level models for clinically significant cancer, area under the receiver operating characteristic curve (AUROC) values clustered around 0.76–0.81; one lesion-level framework reported an AUROC of 0.92, though at a non-comparable analytical unit. Segmentation studies achieved accurate prostate delineation (Dice similarity coefficient ≈ 0.94), and a single study demonstrated high-precision 3D registration to whole-mount histopathology (Dice similarity coefficient 0.97 and landmark error < 3 mm). All studies evaluated AI on previously acquired data, without real-time clinical implementation. Conclusions: AI for micro-US shows promising and reproducible early results across detection, segmentation and registration, but evidence is still limited. In view of the potential of AI to optimize micro-US utilization and its related advantages, additional efforts are warranted to achieve clinical adoption.Keywords
Funding Information
- Italian Ministry of Health through the "Ricerca Corrente" program granted to IRCCS Humanitas Research Hospital
This publication has 28 references indexed in Scilit:
- AI-Assisted vs Unassisted Identification of Prostate Cancer in Magnetic Resonance ImagesJAMA Network Open, 2025
- Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer DiagnosisJAMA, 2025
- TRUSWorthy: toward clinically applicable deep learning for confident detection of prostate cancer in micro-ultrasoundInternational Journal of Computer Assisted Radiology and Surgery, 2025
- Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing OverdiagnosesThe Prostate, 2025
- Image registration of in vivo micro-ultrasound and ex vivo pseudo-whole mount histopathology images of the prostate: A proof-of-concept studyBiomedical Signal Processing and Control, 2024
- Toward confident prostate cancer detection using ultrasound: a multi-center studyInternational Journal of Computer Assisted Radiology and Surgery, 2024
- Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional studyWorld Journal of Urology, 2023
- TRUSformer: improving prostate cancer detection from micro-ultrasound using attention and self-supervisionInternational Journal of Computer Assisted Radiology and Surgery, 2023
- Diagnostic performance of microUltrasound at MRI‐guided confirmatory biopsy in patients under active surveillance for low‐risk prostate cancerThe Prostate, 2023
- Comparison Between Micro-Ultrasound and Multiparametric MRI Regarding the Correct Identification of Prostate Cancer LesionsClinical Genitourinary Cancer, 2022